Health Care / Chemicals & Pharmaceuticals
Congressional stock trading activity sourced from STOCK Act financial disclosures.
Federal contract context is also available for matched USAspending recipients tied to REGN.
Total Trades
38
Members
12
Purchases
15
Sales
23
Avg Conflict
26%
High Conflict
0
Total disclosed volume: $179,038 - $910,000 · Latest trade: May 15, 2026
Matched federal spending records can add context when a heavily traded company is also receiving public money. These recipient matches come from USAspending and should be read alongside, not instead of, the underlying trade filings.
Matched recipients
1
Tracked awards
15
Matched spending
-$332,045,664
REGENERON PHARMACEUTICALS, INC. matches USAspending recipient REGENERON PHARMACEUTICALS INC, with approximately $-332,045,664 in tracked federal spending during the queried window.
6
Members
21
Trades
14%
Avg Score
6
Members
17
Trades
40%
Avg Score
| Date▼ | Member↕ | Type↕ | Amount↕ | Owner | Conflict↕ |
|---|---|---|---|---|---|
| May 15, 2026 | Gilbert Ray Cisneros, Jr. | sale | $1,001 - $15,000 | self | -- |
| Feb 12, 2026 | m-L000595 | purchase | $1,001 - $15,000 | self | 36% |
| Nov 18, 2025 | Gilbert Ray Cisneros, Jr. | purchase | $1,001 - $15,000 | self | 36% |
| May 15, 2025 | Robert P. Bresnahan, Jr. | purchase | $1,001 - $15,000 | self | 37% |
| Apr 10, 2025 | Byron Donalds | sale | $1,001 - $15,000 | spouse | 36% |
| Apr 10, 2025 | Byron Donalds | sale | $1,001 - $15,000 | self | 36% |
| Apr 8, 2025 | Robert P. Bresnahan, Jr. | sale | $1,001 - $15,000 | self | 37% |
| Apr 7, 2025 | m-S001229 | sale | $15,001 - $50,000 | self | 36% |
| Apr 1, 2025 | Julie Johnson | sale | $1,001 - $15,000 | joint | 36% |
| Feb 25, 2025 | Robert P. Bresnahan, Jr. | sale | $1,001 - $15,000 | self | 37% |
| Feb 12, 2025 | Julie Johnson | sale | $1,001 - $15,000 | joint | 36% |
| Jan 24, 2025 | Josh Gottheimer | sale | $1,001 - $15,000 | joint | 31% |
| Jan 15, 2025 | Julie Johnson | purchase | $1,001 - $15,000 | joint | 36% |
| Nov 29, 2024 | Josh Gottheimer | sale | $1,001 - $15,000 | joint | 1% |
| Nov 19, 2024 | Josh Gottheimer | sale | $1,001 - $15,000 | joint | 1% |
| Nov 13, 2024 | Jonathan L. Jackson | sale | $15,001 - $50,000 | joint | 4% |
| Nov 1, 2024 | Jonathan L. Jackson | sale | $1,001 - $15,000 | joint | 6% |
| Oct 23, 2024 | Josh Gottheimer | sale | $1,001 - $15,000 | joint | 1% |
| Oct 15, 2024 | Greg Landsman | sale | $1,001 - $15,000 | spouse | 42% |
| Jul 1, 2024 | Josh Gottheimer | sale | $1,001 - $15,000 | joint | 1% |
| Apr 4, 2024 | Tommy Tuberville | sale | $1,001 - $15,000 | self | 44% |
| Apr 4, 2024 | Tommy Tuberville | sale | $1,001 - $15,000 | self | 44% |
| Feb 8, 2024 | Josh Gottheimer | sale | $1,001 - $15,000 | joint | 1% |
| Jan 17, 2024 | Jonathan L. Jackson | purchase | $1,001 - $15,000 | joint | 6% |
| Aug 11, 2023 | Greg Landsman | purchase | $1,001 - $15,000 | spouse | 42% |
Other Health Care stocks traded by members of Congress.
Merck & Co., Inc.